Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

732
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
732
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

614
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
614
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

814
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
814
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

442
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
442

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Consequences of patient denial at first exemption request for cardiac transplantation.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2025
Same author

Effect of 6% hydroxyethyl starch 130/0.4 on kidney and haemostatic function in cardiac surgical patients: a randomised controlled trial.

Anaesthesia·2020
Same author

Donors of hearts with increased left ventricular wall thickness: the unresolved issue.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2008
Same author

Clinical course and predictors of pericardial effusion following cardiac transplantation.

Transplantation proceedings·2007
Same author

Potential renal protective benefits of intra-operative BNP infusion during cardiac transplantation.

Transplantation proceedings·2006
Same author

An optical supernova associated with the X-ray flash XRF 060218.

Nature·2006

Related Experiment Video

Updated: Apr 20, 2026

Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

36.3K

Current practice in patient selecting for long-term mechanical circulatory support.

M S Halbreiner1, E Soltesz, R Starling

  • 1Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, 9500 Euclid Ave, J4-133, Cleveland, OH, 44195, USA, halbrem@ccf.org.

Current Heart Failure Reports
|December 1, 2014
PubMed
Summary

Patient selection for mechanical circulatory support has evolved with advanced devices. This review details current strategies for left ventricular assist device (LVAD) implantation, focusing on patient evaluation and optimization for better outcomes.

More Related Videos

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

2.5K
Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
08:49

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems

Published on: August 2, 2024

1.5K

Related Experiment Videos

Last Updated: Apr 20, 2026

Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

36.3K
Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

2.5K
Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
08:49

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems

Published on: August 2, 2024

1.5K

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Medical Devices

Background:

  • Mechanical circulatory support (MCS) has advanced significantly over the last decade.
  • Patient selection criteria for left ventricular assist device (LVAD) implantation have consequently evolved.
  • Optimizing patient selection is crucial for improving outcomes in advanced heart failure treatment.

Purpose of the Study:

  • To review the current state of patient selection for long-term circulatory support devices.
  • To describe the evaluation and optimization processes prior to LVAD implantation.
  • To highlight the impact of device advancements on patient selection.

Main Methods:

  • Literature review of recent studies and clinical guidelines on LVAD patient selection.
  • Analysis of trends in patient demographics and clinical profiles undergoing LVAD implantation.
  • Synthesis of current best practices in pre-implantation patient assessment.

Main Results:

  • Patient selection criteria have broadened, including sicker patients and new indications.
  • Multidisciplinary evaluation is essential for comprehensive risk assessment.
  • Optimization strategies focus on medical, nutritional, and psychosocial factors.

Conclusions:

  • Current patient selection for LVADs is dynamic, driven by technological progress.
  • Thorough pre-implantation evaluation and optimization are key to successful LVAD therapy.
  • Continued research is needed to refine selection criteria and further improve patient outcomes.